Ftse Mib
34.339,32
0,55%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
62.793,44
-0,40%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Brooklyn ImmunoTherapeutics Inc (BTX) Brooklyn ImmunoTherapeutics Inc (BTX) Notizie

BTX

Brooklyn ImmunoTherapeut... (BTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BTX
DataOraFonteTitoloSimboloCompagnia
11/05/202322:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
10/05/202312:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202313:02Edgar (US Regulatory)Annual Report to Security Holders (ars)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202313:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
05/05/202312:31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
25/04/202315:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/04/202322:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202323:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
04/04/202323:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
20/12/202222:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
16/12/202223:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/12/202222:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
07/12/202200:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
02/12/202223:01Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/04/202222:35Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
15/04/202223:10Edgar (US Regulatory)Annual Report (10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/04/202212:31Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
29/11/202112:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202123:12Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202123:00Edgar (US Regulatory)Withdrawal of Registration Statement (rw)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
18/11/202122:52Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
09/11/202122:35GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial ResultsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202122:22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202122:13Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/10/202122:06Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
14/10/202122:15GlobeNewswire Inc.Brooklyn ImmunoTherapeutics to Move Stock Exchange Listing to NasdaqAMEX:BTXBrooklyn ImmunoTherapeutics Inc
12/10/202123:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
01/10/202122:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:BTXBrooklyn ImmunoTherapeutics Inc
23/09/202122:30GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Reports Inducement GrantsAMEX:BTXBrooklyn ImmunoTherapeutics Inc
22/09/202116:07GlobeNewswire Inc.Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical OfficerAMEX:BTXBrooklyn ImmunoTherapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BTX

La tua Cronologia

BIT
BPE
Bper Banca
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
TIT
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network